Leading the Way in Life Science Technologies

GEN Exclusives

More »

Market and Technology Analysis

More »
Jan 14, 2014

Mass Spec Market Snapshot

MS is not just for research anymore.

Mass Spec Market Snapshot

There are currently a large number of laboratory-developed tests based on mass spec.

  • The focus of this GEN Market & Tech Analysis report is to frame some of the market trends operative in the broader mass spectrometry space. Highlights:

    • This technique is not only important in life science research but is also increasing in penetrance into the diagnostics marketplace.
    • A number of LDTs have been launched based on mass spectrometry as a readout, addressing a number of distinct analyte classes.
    • Additionally, IVDs are being launched based on mass spec.
    • Newborn screening and drugs-of-abuse testing are two key diagnostic market segments where mass spectrometry is penetrating.

    CLICK HERE to download the PDF report.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »